Publication: A Potential Noninvasive Neurobiological Test for Alzheimer's Disease
No Thumbnail Available
Open/View Files
Date
1994
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
American Association for the Advancement of Science (AAAS)
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Scinto, L., K. Daffner, D Dressler, B. Ransil, D Rentz, S Weintraub, M Mesulam, and H Potter. 1994. A Potential Noninvasive Neurobiological Test for Alzheimer’s Disease. Science 266, no. 5187: 1051–1054.
Research Data
Abstract
Currently Alzheimer's disease, which affects more than 20 million people worldwide, can only be definitely diagnosed by histological examination of brain tissue obtained at autopsy or biopsy. There is a great need for an early, noninvasive, sensitive, and easily administered diagnostic test of Alzheimer's disease. Here it is reported that patients diagnosed with probable Alzheimer's disease by standard clinical criteria exhibited a marked hypersensitivity in their pupil dilation response to a cholinergic antagonist, tropicamide, placed in their eyes. It was possible to distinguish 18 of 19 individuals (95%) either clinically diagnosed with Alzheimer's disease or classified as suspect Alzheimer's individuals by neuropsychological screening from 30 of 32 normal elderly controls (94%).
Description
Other Available Sources
Keywords
Terms of Use
Metadata Only